Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / CCL5



This biomarker is also known as:
  • MGC17164,
  • t cell-specific protein P228,
  • Small-inducible cytokine A5,
  • small inducible cytokine subfamily A (Cys-Cys), member 5,
  • SCYA5,
  • chemokine (C-C motif) ligand 5,
  • SIS-delta,
  • T-cell-specific protein RANTES,
  • D17S136E,
  • T-cell specific protein p288,
  • Eosinophil chemotactic cytokine,
  • C-C motif chemokine 5,
  • TCP228,
  • eoCP,
  • eosinophil chemotactic cytokine,
  • regulated upon activation, normally T-expressed, and presumably secreted,
  • beta-chemokine RANTES,
  • small inducible cytokine A5 (RANTES),
  • SISd,
  • small-inducible cytokine A5,
  • EoCP,
  • T cell-specific protein P228,

View in BioMuta


From NCBI Gene: This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013]


QA State: Curated
Type: Protein
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Curated


The chemokine CCL5 (RANTES), a major monocyte chemoattractant expressed by breast tumor cells, has been implicated in the progression of breast cancer.

Performance Comment

CCL5 (RANTES) was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.